All In Biotech

NDA 206009 · Nitrous Oxide Corp

Nitrous Oxide, Usp

Nitrous Oxide · Inhalation

Last checked: Nov 20, 2026Latest source record: Sep 3, 2013 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

2013

Sep 3, 2013

Approved uses

1

Original approval plus efficacy supplements

Registered trials

234

36 Phase 3, 16 recruiting

FAERS reports

2,221

2,089 serious, 223 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Nov 10, 2026.

No structured label for this application in openFDA. Older and discontinued products often have none.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Sep 3, 2013 Original approval · Medical Gas
1 products under this application
  • NITROUS OXIDE, USP · NITROUS OXIDE N/A · GAS, INHALATION · Prescription

Clinical trials

Interventional ClinicalTrials.gov studies with "Nitrous Oxide" as an intervention, any sponsor and status, largest first.

All 234 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • drug abuse142
  • drug interaction133
  • cardiac arrest122
  • anaesthetic complication neurological117
  • bradycardia101
  • hypotension96
  • toxicity to various agents90
  • subacute combined cord degeneration84
  • off label use67
  • drug ineffective66
  • drug dependence58
  • hyperthermia malignant53

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
2004100
200551
200739
200861
200974
201077
201145
201243
2013100
201489
2015107
2016103
2017130
2018150
2019128
2020149
2021230
2022133
2023114
202455
2025139
2026102

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 3,050 on PubMed

Sponsor: Nitrous Oxide Corp

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.